Company Valuation: Elliptic Laboratories ASA

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,882 2,295 1,786 1,103 714.9 366.4 - -
Change - -20.36% -22.15% -38.24% -35.2% -48.75% - -
Enterprise Value (EV) 1 2,681 2,129 1,697 1,046 671.8 299.3 315.5 323.3
Change - -20.57% -20.32% -38.34% -35.79% -55.44% 5.4% 2.47%
P/E -252x -71.1x -47.3x 116x -5.14x -11.7x -58.8x 61.3x
PBR 8.41x 7.04x 5.82x 3.39x 3.8x 1.72x 1.73x 1.64x
PEG - -0x -2.9x -1x 0x 0.1x 0.7x -0x
Capitalization / Revenue 45.7x 44.1x 26.1x 8.36x 6.96x 3.59x 3.02x 2.42x
EV / Revenue 42.5x 40.9x 24.8x 7.93x 6.54x 2.93x 2.6x 2.14x
EV / EBITDA -948x -69.1x -50.6x 41.7x -32.5x -50.6x 18x 8.94x
EV / EBIT -241x -50.5x -34.1x 222x -14.8x -9.5x -35.9x 40.7x
EV / FCF -94.3x -59x - - -29.1x -12x -31.6x -323x
FCF Yield -1.06% -1.69% - - -3.44% -8.35% -3.17% -0.31%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.11 -0.31 -0.36 0.09 -1.32 -0.2475 -0.0494 0.0473
Distribution rate - - - - - - - -
Net sales 1 63.04 52.06 68.32 131.9 102.7 102.2 121.3 151.3
EBITDA 1 -2.829 -30.81 -33.52 25.12 -20.68 -5.917 17.56 36.17
EBIT 1 -11.14 -42.13 -49.74 4.71 -45.44 -31.5 -8.792 7.947
Net income 1 -11.16 -32.04 -37.85 8.96 -139 -32.05 -6.465 6.262
Net Debt 1 -201 -165.5 -89.72 -57.04 -43.06 -67.03 -50.86 -43.07
Reference price 2 27.750 22.050 17.040 10.480 6.790 2.900 2.900 2.900
Nbr of stocks (in thousands) 103,842 104,074 104,838 105,275 105,287 126,337 - -
Announcement Date 3/10/22 2/17/23 2/15/24 2/27/25 2/26/26 - - -
1NOK in Million2NOK
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-11.92x2.99x-51.66x-.--% 38.48M
-295.9x5.36x19.98x-.--% 20.06B
151.62x0.72x9.17x-.--% 6.79B
16.13x - - - 4.96B
51.97x1.22x8.8x-.--% 3.09B
23.04x - - - 462M
Average -10.84x 2.57x -3.43x 0% 5.9B
Weighted average by Cap. -131.49x 3.88x 16.29x 0%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ELABS Stock
  4. Valuation Elliptic Laboratories ASA
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!